A detailed history of Wells Fargo & Company transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 185,715 shares of MDXG stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,715
Previous 57,557 222.66%
Holding current value
$1.38 Million
Previous $443,000 190.52%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.16 - $8.08 $789,453 - $1.04 Million
128,158 Added 222.66%
185,715 $1.29 Million
Q1 2024

May 10, 2024

SELL
$7.61 - $8.63 $43,917 - $49,803
-5,771 Reduced 9.11%
57,557 $443,000
Q4 2023

Feb 09, 2024

SELL
$5.7 - $9.14 $222,265 - $356,405
-38,994 Reduced 38.11%
63,328 $555,000
Q3 2023

Nov 13, 2023

BUY
$6.35 - $8.16 $22,047 - $28,331
3,472 Added 3.51%
102,322 $745,000
Q2 2023

Aug 15, 2023

BUY
$3.14 - $6.61 $30,062 - $63,284
9,574 Added 10.72%
98,850 $653,000
Q1 2023

May 12, 2023

BUY
$2.97 - $4.81 $178,847 - $289,648
60,218 Added 207.23%
89,276 $304,000
Q4 2022

Feb 13, 2023

BUY
$2.63 - $3.45 $18,875 - $24,760
7,177 Added 32.8%
29,058 $80,000
Q3 2022

Nov 14, 2022

SELL
$2.71 - $4.22 $18 - $29
-7 Reduced 0.03%
21,881 $63,000
Q2 2022

Aug 12, 2022

SELL
$3.17 - $5.0 $579,881 - $914,640
-182,928 Reduced 89.31%
21,888 $76,000
Q1 2022

May 16, 2022

SELL
$4.27 - $6.27 $371,972 - $546,198
-87,113 Reduced 29.84%
204,816 $966,000
Q4 2021

Feb 14, 2022

BUY
$5.7 - $8.48 $50,405 - $74,988
8,843 Added 3.12%
291,929 $1.76 Million
Q3 2021

Nov 15, 2021

BUY
$5.52 - $15.83 $1.42 Million - $4.08 Million
257,988 Added 1027.92%
283,086 $1.72 Million
Q2 2021

Aug 16, 2021

BUY
$9.02 - $12.72 $73,197 - $103,222
8,115 Added 47.78%
25,098 $314,000
Q1 2021

May 13, 2021

BUY
$8.48 - $11.28 $33,470 - $44,522
3,947 Added 30.28%
16,983 $175,000
Q4 2020

Feb 09, 2021

BUY
$5.32 - $10.17 $69,351 - $132,576
13,036 New
13,036 $119,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $845M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.